V027-0393 Screening compound: 1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(4-tert-butylbenzoyl)piperazine

V027-0393 Screening compound: 1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(4-tert-butylbenzoyl)piperazine
V027-0393 Screening compound: 1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(4-tert-butylbenzoyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V027-0393
1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(4-tert-butylbenzoyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V027-0393

Molecular Formula

C38H38N4O2S (C38 H38 N4 O2 S)

Compound Name

1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-4-(4-tert-butylbenzoyl)piperazine

IUPAC name

1-{[6-(1-benzothiophen-2-yl)-2-(4-methoxyphenyl)imidazo[12-a]pyridin-3-yl]methyl}-4-(4-tert-butylbenzoyl)piperazine

SMILES

CC(C)(C)c(cc1)ccc1C(N1CCN(Cc2c(-c(cc3)ccc3OC)nc(cc3)n2cc3-c2cc(cccc3)c3s2)CC1)=O

InChI

InChI=1S/C38H38N4O2S/c1-38(2,3)30-14-9-27(10-15-30)37(43)41-21-19-40(20-22-41)25-32-36(26-11-16-31(44-4)17-12-26)39-35-18-13-29(24-42(32)35)34-23-28-7-5-6-8-33(28)45-34/h5-18,23-24H,19-22,25H2,1-4H3

InChI Key

WXUURNAWFMXXAP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20495350

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

614.81

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

8.098

Distribution Coefficient, logD

8.097

Water Solubility, LogSw

-6.34

Polar Surface Area

36.706

Acid Dissociation Constant (pKa)

26.99

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

V027-0393 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

PLpro Library (6343 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with V027-0393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V027-0393?
Check Price and Availability of V027-0393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V027-0393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V027-0393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V027-0393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V027-0393 available by request